Skip to main content
Fig. 3 | Cancer Nanotechnology

Fig. 3

From: Non-small cell lung cancer targeted nanoparticles with reduced side effects fabricated by flash nanoprecipitation

Fig. 3

Plot of the cellular uptake of a HCC827 NSCLC cell lines and b HL7702 normal liver cell lines, incubated with free drug, NPs and FA-NPs against different periods of time. Cytotoxicity to c HCC827 NSCLC cell lines, d HL7702 normal cell lines after incubation with free drug, NPs and FA-NPs, at different gefitinib concentrations after incubation of 48 h. *P < 0.05, **P < 0.01 and ***P < 0.001, compared between the indicated groups

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us